Nutriati, Inc.

Nutriati, Inc. is a manufacturer focused on producing innovative plant-based protein ingredients for the food and beverage industry, catering to evolving consumer preferences for healthier alternatives. Nutriati, Inc. was founded in 2013 and operates out of the United States.

The company specializes in plant-based protein ingredients. As of May 2022, Nutriati was acquired by Tate & Lyle PLC from several investors, including Manna Tree Partners and Open Prairie. The CEO of Nutriati is Michael Todd. The firm has completed a total of 6 deals, with the most recent deal occurring on May 3, 2022, which involved a Series C funding round that raised USD 12.

70 mn, bringing the total amount raised to USD 12. 70 mn. Nutriati, Inc. specializes in developing plant-based protein ingredients that cater to the food and beverage sector.

The company’s offerings include high-quality protein extracts derived from pulses and grains, designed to enhance the nutritional profile of food products. The primary customers are food manufacturers and brands looking to incorporate sustainable protein sources into their formulations, particularly in North America and Europe, where there is a rising demand for plant-based options. Nutriati continually innovates its product line to meet industry demands and align with consumer trends. Nutriati, Inc.

generates revenue primarily through the sale of its plant-based protein ingredients to food manufacturers. The revenue model is driven by transactions involving bulk ingredient sales, where clients purchase protein products for use in their formulations. The company may also engage in partnerships with food brands, potentially enhancing its revenue through collaborative product development. Moving forward, Nutriati, Inc.

plans to expand its product offerings by developing new plant-based protein ingredients tailored for specific applications in the food industry, with product launches anticipated in the upcoming year. The company is also targeting market expansion into Asia Pacific by 2024, aiming to tap into the growing demand for plant-based proteins in that region. The recent funding of USD 12. 70 mn from the Series C round will support these initiatives, facilitating research and development for new products and enhancing the company's production capabilities.